Dragonboat Biopharmaceutical Company Limited
8 clinical trials · Sponsor
◉ Watch Dragonboat Biopharmaceutical Company Limited
| Record | Firm | Date |
|---|---|---|
| Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis (NCT07447102) | Dragonboat Biopharmaceutical Company Limited | 2026-04-27 |
| An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors (NCT05212896) | Dragonboat Biopharmaceutical Company Limited | 2021-11-26 |
| An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor (NCT04739111) | Dragonboat Biopharmaceutical Company Limited | 2021-01-29 |
| Phase I Clinical Trial of CDP1 in Patients With Advanced Solid Tumors (NCT04151810) | Dragonboat Biopharmaceutical Company Limited | 2019-12-16 |
| Phase I Clinical Trial of Human Anti-PD-L1 Antibody Injection (LDP) in Patients With Advanced Malignant Tumors (NCT03908814) | Dragonboat Biopharmaceutical Company Limited | 2019-04-27 |
| A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC (NCT03491709) | Dragonboat Biopharmaceutical Company Limited | 2018-07-01 |
Track Dragonboat Biopharmaceutical Company Limited automatically
Every clearance here is in the API, with alerts when new ones post.